Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142675 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142676 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O3 |
| Mol.Wt. | 315.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142677 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4S |
| Mol.Wt. | 366.8g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142678 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4S |
| Mol.Wt. | 366.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142679 |
| CAS No | NA |
| Mol.F. | C15H15ClN2O3S |
| Mol.Wt. | 338.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142680 |
| CAS No | NA |
| Mol.F. | C15H15ClN2O3S |
| Mol.Wt. | 338.81 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142681 |
| CAS No | NA |
| Mol.F. | C17H23N3O5 |
| Mol.Wt. | 349.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142682 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142683 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142684 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142685 |
| CAS No | NA |
| Mol.F. | C11H15N3O5 |
| Mol.Wt. | 269.26 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142686 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142687 |
| CAS No | NA |
| Mol.F. | C10H12BrN3O5 |
| Mol.Wt. | 334.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142688 |
| CAS No | NA |
| Mol.F. | C13H17N3O6 |
| Mol.Wt. | 311.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142689 |
| CAS No | NA |
| Mol.F. | C10H13N3O4 |
| Mol.Wt. | 239.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142690 |
| CAS No | NA |
| Mol.F. | C10H12BrN3O5 |
| Mol.Wt. | 334.13 g/mol |
| INV STATUS | In Stock |